Open-weight commoditization, vendor choice, and export-control uncertainty

Open-weight and domain-specific models compete on price, sovereignty, deployment flexibility, and inference efficiency. A synthetic-hospital benchmark reports a small targeted-SFT model matching a much larger model on diagnosis, while TRACE reports gains from task-aware multimodal clinical trajectories; neither establishes clinical deployment readiness. Dream Labs’ robot performance claims also lack independent validation.